Prenetics Global Limited (PRE)
PRE Stock Price Chart
Explore Prenetics Global Limited interactive price chart. Choose custom timeframes to analyze PRE price movements and trends.
PRE Company Profile
Discover essential business fundamentals and corporate details for Prenetics Global Limited (PRE) to support your stock research and investment decisions.
Sector
Healthcare
Industry
Medical - Diagnostics & Research
IPO Date
16 Jul 2021
Employees
285.00
Website
https://www.prenetics.comCEO
Sheng Wu Yeung
Description
As an investment holding company, Prenetics Global Limited specializes in providing diagnostic and genetic testing services. Its comprehensive product line features CircleDNA, a consumer-oriented genetic analysis solution, and the Circle HealthPod, an advanced health monitoring device. The Circle HealthPod facilitates rapid COVID-19 detection through nucleic acid amplification technology, suitable for both professional point-of-care and personal at-home use. Additionally, the company offers ColoClear, a non-invasive FIT-DNA screening test for colorectal cancer, and Circle SnapShot, a readily available at-home blood testing kit. Other diagnostic solutions in their portfolio include Circle Medical, Circle One, and F1x/Fem. Prenetics Global Limited was founded in 2014 and maintains its headquarters in Quarry Bay, Hong Kong.
PRE Financial Timeline
Browse a chronological timeline of Prenetics Global Limited corporate events including earnings releases, dividend announcements, and stock splits.
Upcoming earnings on 11 Sept 2026
EPS estimate is -$0.48, while revenue estimate is $49.85m.
Earnings released on 10 Jun 2026
EPS came in at -$1.36 falling short of the estimated -$0.49 by -177.55%, while revenue for the quarter reached $35.95m , missing expectations by -0.13%.
Earnings released on 18 Feb 2026
EPS came in at -$0.27 surpassing the estimated -$0.49 by +44.90%, while revenue for the quarter reached $36.60m , beating expectations by +9.47%.
Earnings released on 10 Nov 2025
EPS came in at -$0.41 surpassing the estimated -$0.55 by +25.45%, while revenue for the quarter reached $23.56m , missing expectations by -38.50%.
Earnings released on 12 Sept 2025
EPS came in at -$0.82 falling short of the estimated -$0.71 by -15.49%, while revenue for the quarter reached $17.68m , missing expectations by -18.53%.
Earnings released on 12 Jun 2025
EPS came in at -$0.80 falling short of the estimated -$0.77 by -3.90%, while revenue for the quarter reached $17.31m , beating expectations by +44.27%.
Earnings released on 5 Mar 2025
EPS came in at -$1.29 falling short of the estimated -$0.72 by -78.64%, while revenue for the quarter reached $10.49m , missing expectations by -12.60%.
Earnings released on 27 Nov 2024
EPS came in at -$0.88 surpassing the estimated -$0.93 by +5.38%, while revenue for the quarter reached $7.78m , missing expectations by -15.46%.
Earnings released on 27 Sept 2024
EPS came in at -$0.15 surpassing the estimated -$0.93 by +83.87%, while revenue for the quarter reached $5.94m , missing expectations by -22.84%.
Earnings released on 18 Jun 2024
EPS came in at -$0.38 surpassing the estimated -$1.02 by +62.75%, while revenue for the quarter reached $6.41m , beating expectations by +3.44%.
Earnings released on 26 Mar 2024
EPS came in at $0.90 surpassing the estimated -$4.80 by +118.75%, while revenue for the quarter reached $5.28m , missing expectations by -29.64%.
Earnings released on 20 Nov 2023
EPS came in at -$0.04 surpassing the estimated -$0.82 by +95.12%, while revenue for the quarter reached $4.88m , missing expectations by -52.17%.
Stock split effective on 14 Nov 2023
Shares were split 1 : 15 , changing the number of shares outstanding and the price per share accordingly.
Earnings released on 15 Sept 2023
EPS came in at -$0.15 falling short of the estimated -$0.05 by -200.00%, while revenue for the quarter reached $6.51m , missing expectations by -71.28%.
Earnings released on 5 Jun 2023
EPS came in at -$0.60 falling short of the estimated -$0.06 by -900.00%, while revenue for the quarter reached $4.92m , missing expectations by -81.45%.
Earnings released on 14 Mar 2023
EPS came in at $0.90 surpassing the estimated -$0.09 by +1.10k%, while revenue for the quarter reached $52.32m , missing expectations by -3.88%.
Earnings released on 10 Nov 2022
EPS came in at $4.50 surpassing the estimated -$1.95 by +330.77%, while revenue for the quarter reached $4.30m , missing expectations by -93.55%.
Earnings released on 9 Sept 2022
EPS came in at $0.60 surpassing the estimated -$0.62 by +196.77%, while revenue for the quarter reached $4.18m , missing expectations by -95.06%.
Stock split effective on 18 May 2022
Shares were split 129 : 100 , changing the number of shares outstanding and the price per share accordingly.
Earnings released on 17 May 2022
EPS came in at -$8.73 surpassing the estimated -$19.20 by +54.51%, while revenue for the quarter reached $92.04m , beating expectations by +0.58%.
Earnings released on 4 Mar 2022
EPS came in at -$23.18 , while revenue for the quarter reached $64.72m .
Earnings released on 30 Sept 2021
EPS came in at -$21.29 , while revenue for the quarter reached $74.66m .
PRE Stock Performance
Access detailed PRE performance analysis with candlestick charts, real‑time intraday data and historical financial metrics for comprehensive insights.
Explore Related Stocks
Compare companies within the same sector by viewing performance, key financials, and market trends. Select a symbol to access the full profile.
